$NERV 4 SEC Filings

Filed On	Filing
03 Aug 2026	Form 4: Kaul Inderjit, Director Granted 12,147 Stock Option (right to buy)
05 Jun 2026	Form 4: Ahlholm Frederick W, SVP, CFO and Secretary Granted 680,000 Employee Stock Option (right to buy)
05 Jun 2026	Form 4: Luthringer Remy, Director Granted 1,690,700 Employee Stock Option (right to buy)
05 Jun 2026	Form 4: Laghrissi-Thode Fouzia, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Kupfer David, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Kaul Inderjit, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Van Heek G Jan, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Hasler Hans Peter, Director Granted 50,000 Stock Option (right to buy)
22 Apr 2026	Form 4: O'Connor James Joseph, Chief Business Officer and GC Granted 350,800 Employee Stock Option (right to buy)
01 Apr 2026	Form 4: Kaul Inderjit, Director Granted 12,169 Stock Option (right to buy)
23 Dec 2025	Form 4: Kaul Inderjit, Director Granted 364,504 Stock Option (right to buy)
23 Dec 2025	Form 4: Kupfer David, Director Granted 50,000 Stock Option (right to buy)
23 Dec 2025	Form 4: Hasler Hans Peter, Director Granted 50,000 Stock Option (right to buy)
23 Dec 2025	Form 4: Laghrissi-Thode Fouzia, Director Granted 50,000 Stock Option (right to buy)
23 Dec 2025	Form 4: Van Heek G Jan, Director Granted 50,000 Stock Option (right to buy)
23 Dec 2025	Form 4: Ahlholm Frederick W, SVP, CFO and Secretary Granted 500,000 Employee Stock Option (right to buy)
23 Dec 2025	Form 4: Race Geoff, President Granted 1,500,000 Employee Stock Option (right to buy)
23 Dec 2025	Form 4: Luthringer Remy, Director Granted 2,250,000 Employee Stock Option (right to buy)
18 Nov 2025	Form 4: Kaul Inderjit, Director Granted 9,500 Stock Option (right to buy)
06 Dec 2024	Form 4: Van Heek G Jan, Director Granted 12,500 Stock Option (right to buy)

Comments